U.S. District Judge Lucy Koh sided with Apple this week in a patent dispute that will now prevent Samsung from selling its Galaxy Tab 10.1 tablet in the United States. This marks a significant decision for the mobile marketplace, as Apple has effectively stunted the growth of one of the few legitimate rivals to its industry-leading iPad.
With legislators still struggling to craft an appropriate solution to the hot-button issue of digital copyright enforcement, the Obama administration has extended an olive branch to the general public in hopes of inspiring productive conversations.
As students from around the world migrate to the United States to take advantage of superior post-secondary education opportunities, it appears as though American colleges and universities are getting as much as they give. According to the latest report released by the Partnership for a New American Economy, foreign-born students are behind 76 percent of the patents awarded to the nation's top 10 patent-generating schools.
Biotechnology firms have traditionally been among the most active patrons of the U.S. patent system, filing applications to protect initial ideas and issuing licenses to monetize inventions and further their development. The Biotechnology Industry Organization (BIO) has underscored the power of this relationship once again by quantifying the effects of intellectual property management at all levels of the research life cycle.
The U.S. Patent and Trademark Office has extended the window for its After Final Consideration Pilot (AFCP) in order to further evaluate the program. The pilot program is now set to end on September 30, pushed back from the original June 16 close date.
The U.S. Patent and Trademark Office has consistently embraced the role of facilitator in its dealings with the entrepreneurial community. But as dynamic technologies have posed new questions to the American intellectual property system, not all inventors have been pleased with the answers. To sort out fact from fiction in the complicated relationship between the two sides, attorney Leonid Kravets recently adopted a unique empirical approach.
U.S. Patent and Trademark Office director David Kappos made his way to Capitol Hill this week to testify before the Senate Judiciary Committee in the first oversight hearing for the America Invents Act. Kappos reported consistent compliance with the legislation's prescribed implementation framework and elaborated on future strategies for bringing harmony to the international patent system.
The House Committee on Science, Space and Technology convened this week for an in-depth discussion on how universities can start turning federally funded research projects into private-sector innovation. Legislators were joined by delegates from the Association of University Technology Managers, several state colleges and the Maryland Technology Development Corporation.
As pharmaceutical giant Bristol-Myers Squibb prepares for the impending expiration of patent protection on its flagship heart attack and stroke medication, Plavix, the company has taken itself out of the running for producing a generic version of the drug and will instead focus on developing the industry's next innovation.
Although musical artists have enjoyed the benefit of copyright protections for decades, their counterparts on the silver screen have not been so lucky in the field of intellectual property management. But after years of negotiations, World Intellectual Property Organization officials seem convinced that audiovisual performers will soon be afforded the same "economic and moral rights" that protect musicians.
College students have been gravitating toward the idea of digital textbooks for several years, but copyright protection has been one of the few issues standing in the way of widespread acceptance in the academic publishing community. University of Puerto Rico - Rio Piedras professor Joseph Vogel believes he may have a solution that serves all sides, however, with the debut of a new incentive-based system.
The technology sector has long been regarded as a crucial engine of American innovation, but many fear that recent intellectual property disputes could compromise industry progress. In an effort to bring sanity and civility to the patent litigation landscape, professors Jason Schulz and Jennifer Urban from the University of California - Berkeley recently outlined a new approach to addressing stakeholder concerns.
At the recent D10 conference hosted by All Things Digital, Apple CEO Tim Cook was the latest voice from the software development community suggesting that the current U.S. patent system is "broken" and could be standing in the way of innovation. But although most regulatory bodies will concede that there is room for improvement, the intellectual property management incentives embedded in the current system still have plenty to offer savvy software developers.
As bright, young startups expand to become established market players, intellectual property management should be part of the discussion each time they extend an offer of employment to a new hire. Far too many companies, according to Corporate Counsel, don't realize the intellectual capital they have invested in an employee until that worker moves on to another opportunity.
Following the surge of corporate data breaches reported in recent months, companies across industries have been revising data protection protocols to keep a tighter grip on sensitive customer data. However, it appears that a number of organizations are still leaving their intellectual assets without the benefit of similar security measures.
Pharmaceutical manufacturers in Ireland are preparing to learn a hard lesson regarding the relationship between patent management and employment prospects. As Pfizer continues to sort out the implications of its impending patent cliffs, the drugmaker has decided to eliminate nearly 180 positions from plants across the European country.
As a greater proportion of commercial activities migrate to digital platforms, companies are quickly realizing that trademark management strategies must be as vigilant online as they have been offline. But according to the latest survey conducted by branding experts from Melbourne IT DBS, the legal community is not yet fully prepared to advise potential clients on the risks that could await them on the digital frontier.
As prescription drugs from major manufacturers like Pfizer and Merck prepare to come off patent, stakeholders on all sides of the healthcare community are coming to understand the relationship between intellectual property and the economics of the industry. However, following the release of a new survey detailing a critical shortage of cancer drugs in American hospitals, a variety of misunderstandings have converged to make the patent system an undeserving scapegoat for the issues at hand.
The current class of U.S. legislators is keenly aware of the role intellectual property plays in supporting global competitiveness, as evidenced by the passage of the first large-scale patent system reforms in five decades with the America Invents Act. However, reports have emerged to suggest that Congressional leaders may be willing to limit the functionality of current intellectual property frameworks in the interest of economic security.